¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Hodgkin's sarcoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® sarcoma ÇÑ±Û À°Á¾
¼³¸í   
  »óÇǼ¼Æ÷¿¡¼­ ±â¿øÇÑ ¾Ç¼ºÁ¾¾çÀ» ¾ÏÁ¾(carcinoma)À̶ó°í Çϰí, Áß°£¿±Á¶Á÷¿¡¼­ ±â¿øÇÑ °áÇÕÁ¶Á÷, »À, ±ÙÀ° µî¿¡¼­ ±â¿øÇÑ ¾Ç¼º Á¾¾çÀ» À°Á¾À̶ó°í ÇÑ´Ù. ¿¹¸¦ µé¾î °ñÀ°Á¾(osteosarcoma)¶õ »ÀÀÇ ÀÏÂ÷ÀûÀΠ¾Ç¼º Á¾¾çÀÇ Çϳª·Î »ÀÁ¶Á÷À̳ª ¿¬°ñ Á¶Á÷À» ±Ù°£À¸·Î ÇÏ¿© ¾Ç¼º °áÇÕÁ¶Á÷ ±âÁú·Î ÀÌ·ç¾îÁ® Àִ °ÍÀ» ¸»ÇÔ. ±ÙÀ°À°Á¾, Áö¹æÀ°Á¾, ¼¶À¯À°Á¾µµ ¿©±â¿¡ ¼ÓÇÑ´Ù.
¿µ¹® non-Hodgkin lymphoma ÇÑ±Û ºñÈ£ÁöŲ ¸²ÇÁÁ¾
¼³¸í   
  ¸²ÇÁÁ¾Àº ¸²ÇÁÀý¿¡ »ý±ä ¾Ç¼º Á¾¾çÀ¸·Î ¹éÇ÷º´°ú´Â ´Ù¸£´Ù. ¹éÇ÷º´Àº °ñ¼ö¿¡¼­ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌÁö¸¸, ¸²ÇÁÁ¾Àº ¸²ÇÁÁ¶Á÷¿¡¼­ »ý±ä ¸²ÇÁ±¸¼º ¾Ç¼ºÁ¾¾çÀÌ´Ù. Å©°Ô ¸²ÇÁÁ¾Àº 2°¡Áö·Î ³ª´­ ¼ö Àִ µ¥, È£ÁöŲº´(Hodgkin's lymphoma)°ú ºñÈ£ÁöŲ¸²ÇÁÁ¾(non-Hodgkin's lymphoma)À¸·Î ³ª´­ ¼ö ÀÖ´Ù. ¶ÇÇÑ ºñÈ£ÁöŲ¸²ÇÁÁ¾Àº ¿©·¯ °¡ÁöÀÇ ¼¼Æ÷ÇüÅ¿¡ µû¶ó ³ª´©°í ÀÖ´Ù. ÀÌ º´Àº ´ÜÁö ¸²ÇÁÀý»Ó¸¸ ¾Æ´Ï¶ó Áö¶ó, °ñ¼ö, À̿ܠ´Ù¸¥ ±â°üÀ» Ä§¹üÇÔÀ¸·Î½á ¾Ç¼ºÀ̸ç, »ý¸í¿¡ Å« À§ÇùÀ» ÁØ´Ù. ¾Ç¼º¸²ÇÁÁ¾ÀÇ ÀÏÁ¾. ÀüÀÌÀÇ ÇüŰ¡ ´Ù¾çÇÏ¿©, ÁÖÀ§ ¸²ÇÁÀýÀ» °Ç³Ê¶Ù¾î ´Ù¸¥ ¸²ÇÁÀý·Î ÀüÀÌÇϱ⵵ ÇÑ´Ù. ¶ÇÇÑ ¼¼Æ÷ÀÇ ÇüÅ¿¡ µû¶ó ¿©·¯ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç ´ë°³ Ä¡·á´Â ¹æ»ç¼±Ä¡·á¿Í È­Çпä¹ýÀ» º¹ÇÕÇÏ¿© »ç¿ëÇÑ´Ù.
  
  
¿µ¹® Hodgkin's disease ÇÑ±Û È£ÁöŲº´
¼³¸í   
  ¾Ç¼º¸²ÇÁÁ¾ÀÇ ÇÑ ÇüÅÂÀÌ´Ù. È£ÁöŲº´Àº ¹æ»ç¼± Ä¡·á¿¡ ´ë´ÜÈ÷ ¿¹¹ÎÇØ¼­ ÃæºÐÇÑ ¾çÀÇ ¹æ»ç¼±À¸·Î ¿ÏÀüÇÑ ±ÙÄ¡Àû Ä¡·á°¡ °¡´ÉÇÏ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hodgkin¡¯s disease
    È£ÁöŲº´
  • non-Hodgkin¡¯s lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • alveolar soft part sarcoma
    Æ÷»ó¿¬ºÎÀ°Á¾
  • clear cell sarcoma
    Åõ¸í¼¼Æ÷À°Á¾
  • Ewing¡¯s sarcoma
    À¯À×À°Á¾
  • endometrial stromal sarcoma
    Àڱ󻸷¹öÆÀÁúÀ°Á¾, Àڱ󻸷°£ÁúÀ°Á¾
  • epithelioid sarcoma
    »óÇǸð¾çÀ°Á¾
  • granulocytic sarcoma
    °ú¸³±¸À°Á¾
  • idiopathic hemorrhagic sarcoma
    Ư¹ßÃâÇ÷À°Á¾
  • Kaposi sarcoma
    Ä«Æ÷½ÃÀ°Á¾
  • osteoblastic sarcoma
    »À¸ð¼¼Æ÷À°Á¾, °ñ¸ð¼¼Æ÷À°Á¾
  • osteogenic sarcoma
    »ÀÀ°Á¾, °ñÀ°Á¾
  • osteoid sarcoma
    Dz»ÀÀ°Á¾, À¯°ñÀ°Á¾
  • polymorphous sarcoma
    ´ÙÇüÀ°Á¾, ¿©·¯ÇüÅÂÀ°Á¾
  • pseudo-Kaposi sarcoma
    °ÅÁþÄ«Æ÷½ÃÀ°Á¾, °¡¼ºÄ«Æ÷½ÃÀ°Á¾
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • sarcoma
    À°Á¾
  • sarcoma botryoides
    Æ÷µµÀ°Á¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • non-Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • botryoides sarcoma
    Æ÷µµÀ°Á¾
  • clear cell sarcoma
    Åõ¸í¼¼Æ÷À°Á¾
  • endometrial stromal sarcoma
    Àڱ󻸷¹öÆÀÁúÀ°Á¾, Àڱ󻸷±âÁúÀ°Á¾
  • epithelioid sarcoma
    »óÇǸð¾çÀ°Á¾
  • granulocytic sarcoma
    °ú¸³¼¼Æ÷À°Á¾
  • idiopathic hemorrhagic sarcoma
    Ư¹ßÃâÇ÷À°Á¾
  • osteoblastic sarcoma
    »À¸ð¼¼Æ÷À°Á¾, °ñÇ÷¼ºÀ°Á¾
  • osteogenic sarcoma
    (¢¡osteosarcoma) »ÀÀ°Á¾, °ñÀ°Á¾
  • osteoid sarcoma
    À¯°ñÀ°Á¾, Dz»ÀÀ°Á¾
  • parosteal sarcoma
    »ÀÁÖÀ§À°Á¾, ¹æ°ñÀ°Á¾
  • periosteal sarcoma
    »À¸·À°Á¾, °ñ¸·À°Á¾
  • polymorphous sarcoma
    ´ÙÇüÅÂÀ°Á¾, ¿©·¯ÇüÅÂÀ°Á¾
  • pseudo-Kaposi sarcoma
    °ÅÁþÄ«Æ÷½ÃÀ°Á¾
  • reticulum cell sarcoma
    ±×¹°¼¼Æ÷À°Á¾, ¼¼¸Á¼¼Æ÷À°Á¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Ewings sarcoma
    À¯À× À°Á¾.
  • Ewings sarcoma
    À¯À×À°Á¾.
  • Kaposi s sarcoma
    Ä«Æ÷½ÃÀ°Á¾.
  • Kaposis sarcoma
    Ä«Æ÷½ÃÀ°Á¾
  • Kaposis sarcoma (KS)
    Ä«Æ÷½ÃÀ°Á¾
  • Rous sarcoma virus
    ¶ó¿ì½º À°Á¾¹ÙÀÌ·¯½º
  • african kaposis sarcoma
    ¾ÆÇÁ¸®Ä« Ä«Æ÷Áö À°Á¾(¡­ë¿ðþ)
  • gastric sarcoma
    À§À°Á¾.
  • granulocytic sarcoma
    °ú¸³¼¼Æ÷ À°Á¾
  • idiopathic hemorrhagic sarcoma
    Ư¹ß¼º ÃâÇ÷¼º À°Á¾
  • polymorphous sarcoma
    ´ÙÇü(¼º) À°Á¾(Òýû¡(àõ) ë¿ðþ)
  • pulmonary sarcoma
    ÆóÀ°Á¾(øËë¿ðþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hodgkins disease,lacunar cell in
    ¿­°ø¼¼Æ÷
  • hodgkins disease,lymphocyte predominance
    ¸²ÇÁ±¸ ÇöÀúÇü
  • hodgkins disease,mixed cellularity
    È¥ÇÕ¼¼Æ÷Çü
  • hodgkins disease,nodular sclerosis
    °áÀý¼º °æÈ­¼º
  • hodgkins disease,reed-sternberg cell in
    ¸®À̵å-½ºÅ׸¥º£¸£±× ¼¼Æ÷
  • non-Hodgkins lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • non-hodgkins lymphoma
    ¸û¸ù¸û¸²ÇÁÁ¾(¡­ðþ)
  • african kaposis sarcoma
    ¾ÆÇÁ¸®Ä« Ä«Æ÷Áö À°Á¾(¡­ë¿ðþ)
  • avian sarcoma virus
    Á¶·ùÀ°¾ÆÁ¾¹ÙÀÌ·¯½º
  • avian sarcoma virus
    Á¶·ù À°¾ÆÁ¾¹ÙÀÌ·¯½º
  • clear cell sarcoma
  • endometrial stromal sarcoma
    Àڱ󻸷 °£ÁúÀ°Á¾
  • epithelioid sarcoma
    »óÇǾç À°Á¾
  • ewings sarcoma
    À¯À®À°Á¾(¡­ë¿ðþ)
  • gastric sarcoma
    À§À°Á¾.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • avian sarcoma virus
    ±Ý·ùÀ°Á¾(ÐØ×¾ë¿ðþ) ¹ÙÀÌ·¯½º
  • Rous sarcoma
    ¶ó¿ì½º À°Á¾(ë¿ðþ)
  • Rous sarcoma virus
    ¶ó¿ì½º À°Á¾(ë¿ðþ) ¹ÙÀÌ·¯½º
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hodgkin's disease
    È£ÁîŲº´
  • non-Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • immunoblastic sarcoma
    ¸é¿ª¾Æ¼¼Æ÷À°Á¾
  • Kaposi's sarcoma
    Ä«Æ÷½ÃÀ°Á¾
  • osteogenic sarcoma
    °ñ¿ø¼ºÀ°Á¾
  • parosteal sarcoma
    ¹æ°ñ¼ºÀ°Á¾
  • reticulum cell sarcoma
    ¼¼¸Á¼¼Æ÷À°Á¾
  • sarcoma
    À°Á¾
  • sarcoma botryoides
    º¸Å丮¿ÀÀ̵åÀ°Á¾
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MSV maximum sustained level of ventilation; mean scale value; mean spatial velocity; Moloney sarcoma vir...
HD   1) Hodgkin's Disease
  2) Hemo-Dialysis
  3) High Density
&...
NHL Non-Hodgkin's Lymphoma
HD Haab-Dimmer [syndrome]; Hajna-Damon [broth]; Hansen disease; hearing distance; heart disease; helix ...
HL hairline; hairy leukoplakia; half life; hearing level; hearing loss; heparin lock; histiocytic lymph...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AIDS-NHL AIDS-related non-Hodgkin lymphomas
B-NHL B cell non Hodgkin's lymphoma
B-NHL B non Hodgkin's lymphoma
NHL Non Hodgkin Lymphoma
HD HODGKIN'S DISEASE
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Hodgkin's disease
    È£ÁîŲ º´, È£ÁöŲ º´, Hodgkin º´
    µ¿ÀǾî=malignant lym
  • non-Hodgkin lymphoma
    ºñÈ£ÁöŲ ¸²ÇÁÁ¾
  • African kaposis sarcoma
    ¾ÆÇÁ¸®Ä« Ä«Æ÷Áö À°Á¾
  • ameloblastic sarcoma
    ¹ý¶û¾Æ À°Á¾
  • clear cell sarcoma
    Åõ¸í ¼¼Æ÷ À°Á¾
  • endometrial stromal sarcoma
    Àڱ󻸷 ±âÁú À°Á¾
    Àú¾Ç¼º°ú °í¾Ç¼º Á¾¾çÀ¸·Î ±¸ºÐµÈ´Ù. Æò±Õ ¿¬·ÉÀº 42-53¼¼ÀÌ°í ¹Ý¼ö À̻󿡼­ Æó°æ±â ÀÌÀü¿¡ »ý±ä´Ù. ÁÖ Áõ»óÀº ÀÌ»ó ÀÚ±ÃÃâÇ÷, ÁÖ±âÀû ºÎÁ¤ Àڱà ÃâÇ÷ ¹× º¹ºÎ µ¿Åë µîÀÌ´Ù. ÈçÈ÷ ÀÚ±ÃÀÌ Ä¿Áö¹Ç·Î ÀÓ»óÀûÀ¸·Î ÀڱñÙÁ¾À¸·Î Áø´ÜµÉ ¶§°¡ ¸¹´Ù. À°¾ÈÀûÀ¸·Î Àú¾Ç¼ºÀº Àß °æ°èµÇÁö ¾Ê´Â Á¾±«°¡ ÁÖÀ§ÀÇ ±ÙÃþÀ¸·Î Ȳ°¥»öÀÇ ¼Ò°áÀýó·³ ħÀ±Çذ¡´Â °Í°ú ¶Ñ·ÇÇÑ Á¾±« Çü¼º ¾øÀÌ ÀڱñÙÃþÀÌ ¹Ì¸¸¼ºÀ¸·Î ºñÈĵǴ °Í, Á¾±«°¡ ±ÙÁ¾Ã³·³ ÁÖº¯ ºÎÀ§¿¡¼­ À¶±âµÇ¾î º¸ÀÌÁö¸¸ Àý´Ü¸éÀÌ È²°¥»öÀÌ°í ¿¬ÇÏ¿© ±ÙÁ¾°ú´Â ´Ù¸¥ °æ¿ìÀÇ ¼¼ °¡Áö ÇüŸ¦ ÃëÇÑ´Ù. °í¾Ç¼ºÀº ¿¬ÇÏ°í °í±â µ¢¾î¸® °°Àº ¿ëÁ¾¼º Á¾¾çÀ¸·Î Àڱó» °­ ¾ÈÀ¸·Î ÅÍÁ® ³ª¿Í ³»°­À» ä¿ì°Ô µÈ´Ù. ´Ù¹ß¼ºÀ̰í ÃâÇ÷°ú ±«»ç¸¦ ÈçÈ÷ º¸À̸ç Àڱñ٠ÃþÀ¸·Î ħÀ±ÇÑ´Ù.
  • Ewing's sarcoma
    Ewing À°Á¾, À¯À× À°Á¾
    °ñ¼ö·ÎºÎÅÍ ¹ß»ýÇÏ´Â ¾Ç¼º °ñ Á¾¾çÀÎ ³»ÇǼº °ñ¼öÁ¾À¸·Î¼­ ÅëÁõ, ¹ß¿­, ¹éÇ÷±¸ Áõ°¡ÁõÀ» µ¿¹ÝÇϸ鼭 Àå°ñ¿¡¼­ °¡Àå ÈçÇÏ´Ù.
  • Kaposi's sarcoma
    Ä«Æ÷½Ã À°Á¾, Kaposi À°Á¾
    ÇǺο¡¼­ ¹ß»ýÇϴ ƯÀÌÇÑ Ç÷°üÁ¾. ¼­¼­È÷ ÁøÇàµÇ´Â ¾Ç¼º °£¿± Á¶Á÷ Á¾¾çÀ¸·Î, 40-70¼¼ ³²ÀÚÀÇ ÇÏÁö¿¡¼­ È£¹ßÇÑ´Ù. ÀÓ»óÀûÀ¸·Î º´¼Ò´Â ÇǺΠ¾î´À ºÎÀ§¿¡¼­³ª ³ªÅ¸³¯ ¼ö ÀÖÀ¸³ª Ãʱ⿡´Â ´Ù¹ß¼ºÀÎ ÀÛÀº ÀûÀÚ»ö ¹Ý, ¶Ç´Â ±¸Áø°ú °áÀýÀÇ ÇüÅ·Π³ªÅ¸³­´Ù. °á±¹ È®´ëµÇ°í ¼­·Î À¶ÇÕÇÏ¿© ÀûÀÚ»ö Ç÷°ü Á¾¾çÀ» Çü¼ºÇÑ´Ù. ÈÄõ¼º ¸é¿ª °áÇÌÁõÀ̳ª ¾ÆÇÁ¸®Ä«Çü¿¡¼­´Â Àü½ÅÀûÀ¸·Î Àß ¹ß»ýÇÏ¸ç ¸ñ ¸²ÇÁÀý, Ÿ¾×¼±, ¾È¿Í¼± µéÀÌ º¸Åë óÀ½¿¡ ħ¹üµÇ°í, ³»ºÎ Àå±âÀÇ Ä§¹üÀº ´ë°³´Â ÇÕº´ÁõÀÌ´Ù.
  • oral kaposis sarcoma
    ±¸³» Ä«Æ÷½Ã ¾ÏÁ¾
  • osteoblastic sarcoma
    °ñÇü¼º¼º À°Á¾
  • osteogenic sarcoma
    °ñ¿ø¼º À°Á¾, °ñ À°Á¾
    »À¿¡¼­ ¹ß»ýÇÏ´Â °áÇÕÁ¶Á÷ÀÇ Á¾¾ç.
  • polymorphous sarcoma
    ´ÙÇü¼º À°Á¾
  • Rous sarcoma
    ¶ó¿ì½º À°Á¾
    1910³â F.P. ¶ó¿ì½º°¡ ¹ß°ßÇÑ À̽ÄÀÌ °¡´ÉÇÑ ´ßÀÇ ¹ÙÀÌ·¯½º ¾ÏÀ¸·Î ¾Ë·ÁÁø ¹æÃßÇü ¼¼Æ÷À°Á¾. À°Á¾ ¼¼Æ÷¸¦ ÇÔÀ¯ÇÏÁö ¾Ê´Â ¿©°ú¾×¿¡ ÀÇÇÏ¿© À̽ÄÀÌ °¡´ÉÇÏ´Ù´Â °ÍÀ» ¹ß°ßÇϰí, ±× ÈÄ¿¡ ±× ÀÎÀÚ°¡ ¹ÙÀÌ·¯½º¶ó´Â °ÍÀ» ¹ß°ßÇÔÀ¸·Î½á ³ëº§ »ý¸®, ÀÇÇлóÀ» ¹Þ¾Ò´Ù. ¿À´Ã³¯ ¹ß¾Ï ¹ÙÀÌ·¯½ºÀÇ ¿¬±¸¿¡ ³Î¸® ÀÌ¿ëµÇ°í ÀÖ´Ù.
  • sarcoma
    À°Á¾
    żºÀÇ °áÇÕ Á¶Á÷°ú Èí»çÇÑ ¹°Áú·Î µÈ Á¾¾çÀ¸·Î¼­, Á¶Á÷Àº ¼¼¼¶À¯ ¶Ç´Â ±ÕÁú ¹°Áú¿¡ Æ÷¸ÅµÈ Ä¡¹ÐÇÏ°Ô Ã¤¿öÁø ¼¼Æ÷·Î ÀÌ·ç¾îÁ®ÀÖ´Ù. À°Á¾Àº Á¾Á¾ °íµµ·Î ¾Ç¼ºÀÌ´Ù.
  • sclerosing osteogenic sarcoma
    °æÈ­¼º °ñ À°Á¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
cancer, hodgkin's disease A type of lymphoma (cancer of the lymphatic system). The most common symptom of Hodgkin's disease is a painless swelling in the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment for Hodgkin's disease. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia.
(12 Dec 1998)
cancer, lymphoma, hodgkin's A type of lymphoma (cancer of the lymphatic system). The most common symptom of Hodgkin's disease is a painless swelling in the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment for Hodgkin's disease. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia.
(12 Dec 1998)
cancer, lymphoma, non-hodgkin's A lymphoma is a cancer that develops in the lymphatic system. The most common symptom of non-Hodgkin's lymphomas is a painless swelling in the lymph nodes in the neck, underarm, or groin. Non-Hodgkin's lymphomas are diagnosed with a biopsy of an enlarged lymph node. Follow-up examinations are important after lymphoma treatment. Most relapses occur in the first 2 years after therapy.
(12 Dec 1998)
Goldman-Hodgkin-Katz equation An equation derived to predict membrane potentials in terms of the membrane's permeability to ions and their concentrations on either side.
Synonym: constant field equation, Goldman-Hodgkin-Katz equation, GHK equation.
(05 Mar 2000)
Hodgkin, Alan <person> British physiologist and Nobel laureate, *1914.
See: Goldman-Hodgkin-Katz equation.
(05 Mar 2000)
Hodgkin-Key murmur <cardiology, clinical sign> A musical diastolic murmur associated with retroversion of an aortic cusp; often very loud.
(05 Mar 2000)
Hodgkin's disease <haematology, oncology> A human malgnant disorder of lymph tissue (lymphoma) that appears to originate in a particular lymph node and later spreads to the spleen, liver and bone marrow. It occurs mostly in individuals between the ages of 15 and 35. It is characterised by progressive, painless enlargement of the lymph nodes, spleen and general lymph tissue.
Giant cells, the Reed Sternberg cells, with mirror image nuclei are diagnostic. Immunological depletion, caused perhaps by the excessive growth of neoplastic histiocytes, occurs.
Four types of the disease are recognised depending on the relative predominance of various neoplastic derivatives of the lymphoid series. Pyrexia is often a feature of the disease.
Death often results from generalised immunological inability to respond to infections. If detected early, it has a high remission rate.
Staging: Ann Arbor classification; each stage is further classified as:, A no symptoms, B fever, sweats, weight loss.
Stage I - involvement of a single lymph-node region or extralymphatic site.
Stage II - two or more sites of involvement on the same side of the diaphragm.
Stage III - disease involvement on both sides of the diaphragm.
Stage IV - disseminated disease of extralymphatic organs, with or without lymph-node involvement.
Indicence: approximately 1,500 new cases per year in the UK.
(30 Mar 2000)
Hodgkin's lymphoma <haematology, oncology> A human malgnant disorder of lymph tissue (lymphoma) that appears to originate in a particular lymph node and later spreads to the spleen, liver and bone marrow. It occurs mostly in individuals between the ages of 15 and 35. It is characterised by progressive, painless enlargement of the lymph nodes, spleen and general lymph tissue.
Giant cells, the Reed Sternberg cells, with mirror image nuclei are diagnostic. Immunological depletion, caused perhaps by the excessive growth of neoplastic histiocytes, occurs.
Four types of the disease are recognised depending on the relative predominance of various neoplastic derivatives of the lymphoid series. Pyrexia is often a feature of the disease.
Death often results from generalised immunological inability to respond to infections. If detected early, it has a high remission rate.
Staging: Ann Arbor classification; each stage is further classified as:, A no symptoms, B fever, sweats, weight loss.
Stage I - involvement of a single lymph-node region or extralymphatic site.
Stage II - two or more sites of involvement on the same side of the diaphragm.
Stage III - disease involvement on both sides of the diaphragm.
Stage IV - disseminated disease of extralymphatic organs, with or without lymph-node involvement.
Indicence: approximately 1,500 new cases per year in the UK.
(30 Mar 2000)
Hodgkin, Thomas <person> British physician, 1798-1866.
See: Hodgkin's disease, Hodgkin-Key murmur, non-Hodgkin's lymphoma.
(05 Mar 2000)
non-Hodgkin's lymphoma <oncology, tumour> A group of lymphomas which differ in important ways from Hodgkin's disease and are classified according to the microscopic appearance of the cancer cells. The disease is classified as either low grade (slowly growing), intermediate grade or high grade (rapidly growing) and may be treated in a variety of ways depending on the exact diagnosis. Previously called lymphosarcoma.
(30 Sep 1997)
disease, hodgkin's A type of lymphoma (cancer of the lymphatic system). The most common symptom is painless swelling of the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia.
A disease of the lymph nodes named after the English physician Thomas Hodgkin (1798-1866) who discovered it.
(12 Dec 1998)
lymphoma, non-hodgkin Any of a group of malignant tumours of lymphoid tissue that differ from hodgkin disease, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumours is the absence of giant reed-sternberg cells, a characteristic of hodgkin's disease.
(12 Dec 1998)
alveolar soft part sarcoma <tumour> A malignant tumour formed of a reticular stroma of connective tissue enclosing aggregates of large round or polygonal cells; occurs in subcutaneous and fibromuscular tissues.
(05 Mar 2000)
ameloblastic sarcoma <tumour> A rapidly growing, painful, destructive, radiolucent odontogenic tumour that usually arises through malignant change in the mesenchymal component of a pre-existing ameloblastic fibroma.
Synonym: ameloblastic sarcoma.
(05 Mar 2000)
angiolithic sarcoma <tumour> A firm cellular neoplasm derived from fibrous tissue of the meninges, choroid plexus, and certain other structures associated with the brain, characterised by the formation of multiple, discrete, concentrically laminated, calcareous bodies (psammoma bodies); most of these neoplasms are histologically benign, but may lead to severe symptoms as a result of compressing the brain.
Synonym: angiolithic sarcoma, sand tumour, Virchow's psammoma.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hodgkin's disease
    È£ÁöŲ º´(¾Ç¼º À°¾ÆÁ¾Áß)
  • sarcoma
    À°Á¾
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á